Episode 155: GLP-1, Weight Loss & Kidney Transplant Eligibility | Beyond The Scale (Part 2) Podcast By cover art

Episode 155: GLP-1, Weight Loss & Kidney Transplant Eligibility | Beyond The Scale (Part 2)

Episode 155: GLP-1, Weight Loss & Kidney Transplant Eligibility | Beyond The Scale (Part 2)

Listen for free

View show details
GLP-1 medications are being talked about everywhere right now — but what do they mean for people living with chronic kidney disease and dialysis? In Part 2 of this two-part series, we focus on GLP-1 receptor agonists, how these medications work, and what kidney patients need to understand when considering weight loss treatments in the context of kidney transplant eligibility. For many people living with chronic kidney disease (CKD), weight can influence access to transplant surgery. But navigating weight loss while on dialysis is complex, and treatments like GLP-1 medications should always be considered with specialist guidance. In this episode of the Diary of a Kidney Warrior Podcast, host Dee Moore is joined by Dr Adrian Brown, Associate Professor in Nutrition and Dietetics, NIHR Advanced Fellow, and Senior Specialist Weight-Management and Bariatric Dietitian. Together they explore: • What GLP-1 receptor agonists are and how they work • Why these medications must never be used without medical supervision • The risks of buying weight-loss treatments online • How GLP-1 medications may be considered for some kidney patients • Why conversations about weight and transplant eligibility are often more complex than people realise This episode highlights the importance of evidence-based information, patient safety, and open conversations between patients and their renal teams. ⚠️ This episode is for educational purposes only and does not replace personalised medical advice. Always speak with your healthcare team about your individual circumstances. 🎧 Listen now and continue the conversation. If you found this episode helpful, please consider sharing it with someone navigating chronic kidney disease, dialysis, or kidney transplant pathways. Part 1 of this series explores BMI, dialysis, and kidney transplant eligibility in more detail. Follow Diary of a Kidney Warrior: 📸Instagram: www.instagram.com/diaryofakidneywarrior 📘Facebook: www.facebook.com/diaryofakidneywarrior 🐦Twitter (X): www.twitter.com/diaryofakidneyw 🎵Tik Tok: @diaryofakidneywarrior 📺Youtube: https://www.youtube.com/channel/UChGUfib7lu9eKENlLJ6lafw 🔵 BlueSky: @diaryofakidneyw.bsky.social 💌 Join the Diary of a Kidney Warrior Family Mailing List Get updates on new episodes, vlogs, newsletters, and more! 👉🏽👉 Sign up here: https://diaryofakidneywarrior.getform.com/rjv47 📲 Follow Diary of a Kidney Warrior on WhatsApp Stay updated with new episodes and exclusive content! 👉🏽👉 Join here: https://whatsapp.com/channel/0029VaO3ms71iUxipp1eeh2r Follow Dr Adrian Twitter (X) @brownadey; LinkedIn: Adrian Brown UCL Website: https://profiles.ucl.ac.uk/6560-adrian-brown Kidney Care UK 💻 Website: www.kidneycareuk.org 📧 info@kidneycareuk.org 📞Tel: 01420 541 424 📘Facebook: www.facebook.com/kidneycareuk.org 📷Instagram: @kidneycareuk 🔵Blue Sky: https://bsky.app/profile/kidneycareuk.bsky.social 📺YouTube: https://www.youtube.com/channel/UCeqQTdAsEzXphqjHVtcTD-A 📩 To sign up to receive the Kidney Matters Quarterly Magazine Email: info@kidneycareuk.org Disclaimer: The information shared in this episode is for educational and informational purposes only and does not constitute medical advice. Always consult your doctor, consultant, or qualified healthcare professional regarding your individual health needs and before making any medical decisions. The views expressed by guests are their own and do not necessarily reflect those of the host, the Diary of a Kidney Warrior Podcast, or Kidney Care UK and are not intended to malign any religion, ethnic group, club, organisation, company, individual or anyone or anything. GLP-1 Kidney transplant Chronic kidney disease Dialysis Weight loss Kidney health Transplant eligibility CKD GLP-1 medications Kidney disease podcast
No reviews yet